sq-11725 has been researched along with brl 37344 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horinouchi, T; Koike, K | 1 |
| Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P | 1 |
| Adamo, C; Angelone, T; Cerra, MC; Imbrogno, S; Pulerà, E; Tota, B | 1 |
| Bundgaard, H; Chia, KK; Figtree, GA; Garcia, A; Hamilton, EJ; Huang, Y; Hunyor, SN; Liu, CC; Rasmussen, HH | 1 |
4 other study(ies) available for sq-11725 and brl 37344
| Article | Year |
|---|---|
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation | 2004 |
Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anguilla; Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Depression, Chemical; Ethanolamines; GTP-Binding Proteins; Heart; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Nadolol; Nitric Oxide; Propanolamines; Receptors, Adrenergic, beta-3; Signal Transduction | 2006 |
β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dioxoles; Disease Models, Animal; Ethanolamines; Glutathione; Heart Failure; Mice; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Nadolol; Oxidative Stress; Patch-Clamp Techniques; Rabbits; Receptors, Adrenergic, beta-3; Sheep; Sodium; Sodium-Potassium-Exchanging ATPase | 2010 |